Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) News
Filter ENZ News Items
ENZ News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ENZ News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ENZ News From Around the Web
Below are the latest news stories about ENZO BIOCHEM INC that investors may wish to consider to help them evaluate ENZ as an investment opportunity.
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand ChallengesEnzo Biochem reports a first-quarter fiscal 2025 quarterly loss and revenue drop across regions amid challenges in the life sciences tools market. |
Enzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024)Enzo Biochem ( NYSE:ENZ ) First Quarter 2025 Results Key Financial Results Revenue: US$6.21m (down 20% from 1Q 2024... |
Enzo Biochem: Fiscal Q1 Earnings SnapshotFARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. ENZ) on Monday reported a loss of $3.4 million in its fiscal first quarter. On a per-share basis, the Farmingdale, New York-based company said it had a loss of 7 cents. |
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company UpdateFARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal first quarter ended October 31, 2024. First Quarter Highlights Enzo ended the first quarter with aggregate cash and cash equivalents of $47.7 million. The net cash used in operating activities during the first quarter decreased by $4.4 million compared to the prior year. The Company's first-quarter revenue of $6.2 million declined year-ove |
The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo BiochemAmgen, Eaton, Sony, iMage and Enzo Biochem are included in this Analyst Blog. |
Top Stock Reports for Amgen, Eaton & Enzo BiochemToday's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Eaton Corp. plc (ETN) and Sony Group Corp. (SONY), as well as two micro-cap stocks, Moving iMage Technologies, Inc. (MITQ) and Enzo Biochem, Inc. (ENZ). |
US Penny Stocks To Watch In December 2024As the U.S. market takes a breather from its post-election rally, major indices like the Dow Jones and S&P 500 are seeing slight declines while still riding high on recent record achievements. In this context, penny stocks—often smaller or newer companies—remain an intriguing investment area despite their somewhat outdated label. These stocks can offer unique growth opportunities, especially when backed by solid financials, making them worthy of attention for investors seeking under-the-radar... |
We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn RateJust because a business does not make any money, does not mean that the stock will go down. For example, although... |
Enzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023)Enzo Biochem ( NYSE:ENZ ) Full Year 2024 Results Key Financial Results Revenue: US$31.9m (up 2.7% from FY 2023). Net... |
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin ExpandsEnzo Biochem's overall topline benefits from revenue growth in the majority of its geographic regions. |